In ApcMin/+ mice, three weeks treatment with 25 mg/kg quercetin (oral gavage), after tumor development, reduced muscle atrophy by lowering plasma IL-6 and muscle STAT3 activation [217]. Here, IL6 is linked to neoplasm.